[PDF][PDF] Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12
Journal of clinical oncology, 2010•researchgate.net
Purpose Karyotype is an independent indicator of prognosis in acute myeloid leukemia
(AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the
true prognostic significance of individual chromosomal abnormalities in this age group
remains unclear.
(AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the
true prognostic significance of individual chromosomal abnormalities in this age group
remains unclear.
Purpose
Karyotype is an independent indicator of prognosis in acute myeloid leukemia (AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the true prognostic significance of individual chromosomal abnormalities in this age group remains unclear.
researchgate.net